多中心研究和系统性审查:怀孕期间的阿洛普林醇暴露
Femke Crouwel1, Melek Simsek1, Marjon A de Boer2
1Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Alimentary pharmacology & therapeutics
|July 10, 2024
概括
有限的数据存在于怀孕期间的Allopurinol安全性. 虽然整体产性仍然没有确定性,但在怀孕期间对炎症性肠病 (IBD) 进行的阿洛普林醇/氨酸联合治疗似乎不会增加先天性异常风险.
科学领域:
- 生殖医学是一种生殖医学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 有限的数据存在于怀孕期间的Allopurinol安全性.
- 在子宫内暴露于阿洛普林醇后,调查不良妊娠结果和先天性异常至关重要,特别是在炎症性肠病 (IBD) 患者中.
结论:
- 艾洛普林醇的致性需要进一步调查.
- 在怀孕期间用于IBD的Allopurinol/thiopurine联合治疗似乎不会增加先天性异常的风险.
相关概念视频
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K


